BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 952 filers reported holding BAXTER INTL INC in Q1 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $693,057 | -14.8% | 18,364 | +2.9% | 0.03% | -9.4% |
Q2 2023 | $813,000 | -32.8% | 17,854 | +13.8% | 0.03% | -5.9% |
Q3 2018 | $1,209,000 | +4.1% | 15,689 | -0.2% | 0.03% | -35.8% |
Q2 2018 | $1,161,000 | +12.8% | 15,721 | -0.6% | 0.05% | +15.2% |
Q1 2018 | $1,029,000 | +44.7% | 15,818 | +43.8% | 0.05% | +58.6% |
Q4 2017 | $711,000 | -43.4% | 11,003 | -45.0% | 0.03% | -45.3% |
Q3 2017 | $1,256,000 | +3.8% | 20,003 | +0.1% | 0.05% | +3.9% |
Q2 2017 | $1,210,000 | +16.7% | 19,993 | 0.0% | 0.05% | +18.6% |
Q1 2017 | $1,037,000 | +17.0% | 19,993 | 0.0% | 0.04% | +30.3% |
Q4 2016 | $886,000 | -19.5% | 19,993 | -13.5% | 0.03% | -25.0% |
Q3 2016 | $1,101,000 | +7.2% | 23,123 | +1.7% | 0.04% | +2.3% |
Q2 2016 | $1,027,000 | +37.9% | 22,726 | +25.3% | 0.04% | +38.7% |
Q1 2016 | $745,000 | +148.3% | 18,136 | +319.0% | 0.03% | +106.7% |
Q2 2013 | $300,000 | – | 4,328 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |